Department of Pulmonary and Critical Care Medicine, General Hospital of Western Theater Command, NO.270 Tianhui Road, Rongdu Avenue, Jinniu District, Chengdu, Sichuan Province 610083, China , Ma
Abstract: (40 Views)
Background:Although combination treatment strategies have significantly improved and achieved impressive results, the 5-year survival rate of non-small cell lung cancer (NSCLC) still remains undesirable. Given the rapidly burgeoning concept of neoadjuvant and adjuvant strategies in cancer for increasing the therapeutic benefit, we aimed to explore the importance and trends of adjuvant strategies in NSCLC. Materials and Methods: We performed a visual analysis to evaluate published literature (707 papers) in the field of neoadjuvant and adjuvant strategies in NSCLC from January 1, 2013 to July 6, 2023, and acquire a comprehensive understanding of the field. VOSviewer was used to construct bibliometric networks for 707 related literatures. Results: the counts of publications and the evolution of citations concerning neoadjuvant and adjuvant strategies in NSCLC from 2013 to 2023 indicated the increasing interest and investment in the field of NSCLC neoadjuvance and adjunctive strategies. We detected that the majority of academic papers on neoadjuvant and adjuvant strategies for NSCLC were published in high-quality journals. A keyword screening of the relevant literature showed that the research on neoadjuvant and adjuvant strategies for NSCLC was mainly related to chemotherapy. China and United States were particularly influential and highly prolific in this field. Conclusion: Given this rapidly expanding realm, the neoadjuvant and adjuvant strategies may further improve the prognosis of NSCLC. The visual analysis will promote the development of research on neoadjuvant and adjuvant strategies in NSCLC and provide a reference for further research in this field.